Arrowhead Pharmaceuticals, Inc.

Centiva Capital, LP ARWR

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

5,807

Value ($000)

207

Weight

0.0%

2021 Q2 - 2023 Q2 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	207	0.0%	5,807	6/30/2023
2021 Q3	11/17/2021	206	0.0%	3,300	9/30/2021
2021 Q2	8/16/2021	1,174	0.1%	14,177	6/30/2021